Health Trends 2026 Mercer: What the Mercer Marsh Benefits Report Reveals for UK Employers and Employees

Mercer Marsh Benefits' Health Trends 2026 report, published in October 2026, projects UK employer-sponsored medical costs will rise by 10.5% in 2027, down from 12.5% in 2026, while mental health support, GLP-1 weight management drugs and virtual care move to the centre of corporate health strategies. The report, based on data from more than 2,500 insurers across 58 markets, confirms that UK medical inflation remains roughly four times general inflation, even as it cools from its 2024 peak.

What does the Mercer Marsh Benefits Health Trends 2026 report say about UK medical inflation?

UK medical inflation is forecast at 10.5% for 2027, according to the Mercer Marsh Benefits Health Trends 2026 report, a marked slowdown from 12.5% in 2026 and 14.2% in 2024. The figure still sits far above the UK's general inflation rate, which the Office for National Statistics reported at 2.6% in September 2026, meaning employers face real-terms cost growth of roughly eight percentage points.

Mercer Marsh Benefits attributes the easing to three factors: greater use of negotiated provider networks, wider adoption of virtual-first primary care, and a slowdown in catastrophic claims following the post-pandemic backlog. However, the consultancy warns that GLP-1 prescribing and advanced cancer therapies continue to push severe claims above £250,000 per case.

Why is mental health the number one priority for UK employers in 2026?

Mental health is the top health priority for 68% of UK employers surveyed in the Mercer Marsh Benefits Health Trends 2026 report, up from 54% in 2024. The report links this shift to rising short-term absence, with the ONS reporting 2.8% of working hours lost to sickness in 2026, and to growing demand for counselling, CBT and digital therapy platforms.

Mercer Marsh Benefits data shows that UK employers now spend an average of £185 per employee per year on mental health benefits, a 22% increase on 2025. The report also highlights a sharp rise in manager training programmes, with 41% of UK firms now mandating mental health first aid training for line managers.

Mental health has moved from a peripheral wellbeing perk to a core component of UK benefits strategy, with employers treating it as a retention and productivity issue rather than a compliance exercise. (Mercer Marsh Benefits, Health Trends 2026)

How are GLP-1 drugs changing UK employer health plans in 2026?

GLP-1 weight management drugs such as Wegovy and Mounjaro are now covered by 34% of UK employer health plans, according to the Mercer Marsh Benefits Health Trends 2026 report, up from 12% in 2024. The report notes that employers are increasingly viewing GLP-1 coverage as a way to reduce long-term costs linked to obesity, type 2 diabetes and musculoskeletal conditions.

However, cost remains a barrier. Mercer Marsh Benefits estimates that full GLP-1 coverage adds between 3% and 5% to annual medical plan costs, and the report warns that without strict eligibility criteria, employers risk unsustainable claims growth. The National Institute for Health and Care Excellence (NICE) updated its guidance on tirzepatide in 2026 to include wider NHS access, which has increased pressure on private plans to match public provision.

What role does digital health play in the 2026 Mercer Marsh Benefits findings?

Digital health adoption has reached 79% among UK employers in 2026, up from 61% in 2024, according to the Mercer Marsh Benefits Health Trends 2026 report. Virtual GP services, AI triage tools and remote physiotherapy are now standard components of UK corporate health plans, with employers citing faster access and lower cost per consultation.

The report identifies AI-driven triage as the fastest-growing digital benefit, used by 46% of UK employers in 2026. Mercer Marsh Benefits cautions that data governance and clinical validation remain uneven, and recommends that employers audit digital providers against NHS Digital Technology Assessment Criteria (DTAC) standards.

How do UK health trends compare with global markets in 2026?

UK medical inflation of 10.5% for 2027 is below the global average of 11.2% but above the European average of 9.4%, according to the Mercer Marsh Benefits Health Trends 2026 report. The UK sits mid-table globally, behind markets such as the United States (13.8%) and Brazil (15.1%), but ahead of Germany (8.7%) and France (7.9%).

What should UK employers and employees do with these 2026 findings?

UK employers should renegotiate insurer contracts before the January 2027 renewal cycle, according to Mercer Marsh Benefits, which recommends a three-part strategy: tighten GLP-1 eligibility, expand virtual-first care, and embed mental health metrics into board-level reporting. Employees, meanwhile, should check whether their 2027 benefits package includes digital GP access and mental health counselling, as these are the two areas most likely to change.

The report also urges employers to communicate benefits more clearly, noting that only 38% of UK employees say they fully understand their health benefits, down from 45% in 2024. Mercer Marsh Benefits links this awareness gap to underutilisation of preventive services, which in turn drives higher long-term claims.

Frequently asked questions

What is the Mercer Marsh Benefits Health Trends 2026 report?

It is an annual global study published by Mercer Marsh Benefits that analyses medical inflation, employer health priorities and benefit design across 58 markets, including the UK. The 2026 edition forecasts UK medical inflation at 10.5% for 2027.

How much is UK medical inflation in 2026?

UK medical inflation is 12.5% in 2026, according to Mercer Marsh Benefits, falling to a forecast 10.5% in 2027. This compares with general UK inflation of 2.6% in September 2026, as reported by the ONS.

Are GLP-1 drugs covered by UK employer health plans in 2026?

Yes, 34% of UK employer health plans now cover GLP-1 weight management drugs, up from 12% in 2024, according to the Mercer Marsh Benefits Health Trends 2026 report.

What is the top health priority for UK employers in 2026?

Mental health is the top priority for 68% of UK employers in 2026, followed by GLP-1 and weight management coverage, and digital health integration.